Jul 6, 2026 08:01AM
Jul 6, 2026 08:00AM
May 26, 2026 07:00AM
May 26, 2026 07:00AM
May 14, 2026 08:01AM
May 14, 2026 08:00AM
May 12, 2026 08:00AM Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
May 5, 2026 08:00AM
Apr 22, 2026 08:00AM
Apr 7, 2026 02:49PM
Apr 7, 2026 08:06AM
Apr 7, 2026 08:00AM
Mar 9, 2026 07:30AM
Nov 12, 2025 08:00AM Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Oct 20, 2025 08:18AM
Oct 20, 2025 06:56AM
Oct 18, 2025 03:00AM
Oct 14, 2025 08:01AM
Oct 14, 2025 08:00AM
Sep 18, 2025 06:39AM
Sep 16, 2025 08:01AM FDA grants Fast Track status to Corbus' CRB-701 for head and neck cancer
Sep 16, 2025 08:00AM
Sep 11, 2025 08:18AM
Aug 5, 2025 08:00AM
May 7, 2025 07:17AM
May 6, 2025 08:00AM
Mar 12, 2025 06:40AM
Mar 11, 2025 08:00AM Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
Jan 2, 2025 12:51PM
Dec 3, 2024 07:00AM
Dec 3, 2024 07:00AM
Aug 6, 2024 08:00AM
May 7, 2024 08:00AM
Apr 24, 2024 04:05PM
Apr 2, 2024 08:00AM Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
Mar 12, 2024 08:00AM
Jan 26, 2024 07:30AM
Jan 26, 2024 07:30AM
Jan 23, 2024 08:00AM
Jan 9, 2024 08:00AM
Dec 18, 2023 08:00AM
Nov 7, 2023 08:00AM Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Oct 3, 2023 08:00AM
Aug 8, 2023 08:00AM
May 9, 2023 08:00AM
Feb 13, 2023 06:56AM
Feb 13, 2023 06:55AM
Mar 2, 2022 07:02AM
Mar 2, 2022 07:00AM Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
Nov 16, 2021 08:45AM

325,738 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All